HomeCompareJVSAR vs JNJ

JVSAR vs JNJ: Dividend Comparison 2026

JVSAR yields 229.89% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JVSAR wins by $273.54M in total portfolio value
10 years
JVSAR
JVSAR
● Live price
229.89%
Share price
$0.87
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$273.56M
Annual income
$147,417,011.12
Full JVSAR calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — JVSAR vs JNJ

📍 JVSAR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodJVSARJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, JVSAR + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
JVSAR pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

JVSAR
Annual income on $10K today (after 15% tax)
$19,540.23/yr
After 10yr DRIP, annual income (after tax)
$125,304,459.45/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JVSAR beats the other by $125,303,755.84/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of JVSAR + JNJ for your $10,000?

JVSAR: 50%JNJ: 50%
100% JNJ50/50100% JVSAR
Portfolio after 10yr
$136.79M
Annual income
$73,708,919.45/yr
Blended yield
53.88%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

JVSAR
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

JVSAR buys
0
JNJ buys
0
No recent congressional trades found for JVSAR or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricJVSARJNJ
Forward yield229.89%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$273.56M$20.0K
Annual income after 10y$147,417,011.12$827.78
Total dividends collected$259.68M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: JVSAR vs JNJ ($10,000, DRIP)

YearJVSAR PortfolioJVSAR Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$33,689$22,988.51$10,676$355.77+$23.0KJVSAR
2$108,425$72,378.36$11,407$389.39+$97.0KJVSAR
3$333,722$217,707.23$12,198$426.53+$321.5KJVSAR
4$983,328$626,245.04$13,056$467.62+$970.3KJVSAR
5$2,776,703$1,724,542.37$13,987$513.12+$2.76MJVSAR
6$7,522,223$4,551,151.29$14,998$563.56+$7.51MJVSAR
7$19,571,480$11,522,701.34$16,098$619.52+$19.56MJVSAR
8$48,960,184$28,018,699.69$17,295$681.69+$48.94MJVSAR
9$117,893,771$65,506,373.98$18,599$750.82+$117.88MJVSAR
10$273,563,346$147,417,011.12$20,022$827.78+$273.54MJVSAR

JVSAR vs JNJ: Complete Analysis 2026

JVSARStock

JVSPAC Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire businesses in the lifestyle sector and technology. The company was incorporated in 2021 and is based in Wan Chai, Hong Kong. JVSPAC Acquisition Corp. operates as a subsidiary of Winky Investments Limited.

Full JVSAR Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this JVSAR vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

JVSAR vs SCHDJVSAR vs JEPIJVSAR vs OJVSAR vs KOJVSAR vs MAINJVSAR vs ABBVJVSAR vs MRKJVSAR vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.